To check TEC enrichment after isolation, cells were incubated with
anti‐CD45 (
clone 30‐F11, BioLegend, San Diego, CA),
anti‐EpCam (clone G8.8, BioLegend),
anti‐Ly5.1 (clone 6C3, Miltenyi), anti‐Ulex Europeaus agglutinin I (clone FL‐1061, Vector Laboratories, Burlingame, CA), and
anti‐Major Histocompatibility Complex (MHC) class II (clone M5/114.15.2, BioLegend) antibodies. Exclusion of dead cells was done adding 200 μg/ml of DAPI solution just before acquisition.
For the evaluation of epithelial stem‐progenitor markers, cells were incubated with
anti‐EpCam (clone G8.8, BioLegend), anti‐OCT4 (clone EM92, Ebioscience),
anti‐CD44 (clone IM7, BD, Biosciences, San Jose, CA),
anti‐Sca‐1 (clone D7, BioLegend), anti‐CD90 (clone 30 H‐12, BioLegend), and anti‐MHC II (clone M5/114.15.2, BioLegend) antibodies.
At the time of sacrifice, mice were euthanized according to the ethical guidelines. Spleen, lymph nodes, and blood samples were prepared using standard protocols and analyzed with
anti‐CD45 (
clone 30‐F11, BioLegend),
anti‐CD3 (clone 145‐2C11, BD, Biosciences),
anti‐CD4 (clone RM4‐5, BD, Biosciences), and
anti‐CD8 (clone 53–6.7, BD, Biosciences) antibodies.
Cells were acquired on a
FACS‐Canto II or
LSR Fortessa flow cytometer (BD, Biosciences) and analyses were performed using the
FlowJo software (FlowJo, LLC, Ashland, OR).
Bortolomai I., Sandri M., Draghici E., Fontana E., Campodoni E., Marcovecchio G.E., Ferrua F., Perani L., Spinelli A., Canu T., Catucci M., Di Tomaso T., Sergi Sergi L., Esposito A., Lombardo A., Naldini L., Tampieri A., Hollander G.A., Villa A, & Bosticardo M. (2019). Gene Modification and Three‐Dimensional Scaffolds as Novel Tools to Allow the Use of Postnatal Thymic Epithelial Cells for Thymus Regeneration Approaches. Stem Cells Translational Medicine, 8(10), 1107-1122.